Merus NV (FRA:2GH)
€ 48.8 1.4 (2.95%) Market Cap: 3.27 Bil Enterprise Value: 2.97 Bil PE Ratio: 0 PB Ratio: 8.88 GF Score: 57/100

Merus NV MCLA-129 Call Transcript

Oct 26, 2022 / 11:30AM GMT
Release Date Price: €19.5
Operator

Thank you for standing by, and welcome to the Merus investor call. (Operator Instructions) I would now like to turn the conference over to Kathleen Farren, investor relations and corporate communications. Ms. Farren, please go ahead.

Kathleen Farren
Merus N.V. - Investor Relations and Corporate Communications

Good afternoon from Barcelona. Thank you for joining our call and for joining so early for those of you in the U.S. The purpose of this call is to discuss the data presented in the poster session of this year's EORTC-NCI-AACR meeting, which we also refer to as the triple meeting. The slide presentation is available on our website at www.merus.nl.

On this call, we will be making certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These may include statements about our future expectations and plans and events and circumstances, including about finances, intellectual property, projections about Merus' clinical development for 2022

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot